Cartherics Pty, a biotechnology company developing off-the-shelf immune cell therapies for high-impact women’s diseases, including ovarian cancer and endometriosis, and Catalent has announced an enhanced partnership.
Thermo Fisher Scientific, has announced the global launch of the Gibco CTS Compleo Fill and Finish System, an automated, functionally closed solution designed to streamline formulation and filling in cell therapy manufacturing.
Bracco Imaging announced an upgrade of its manufacturing site in Geneva to support clinical-grade GMP manufacturing of its cell therapy-enabling microbubble technology, building on its previously announced Investments in the site since 2019.
Trenchant BioSystems and Invetech have announced that they have entered into a strategic alliance. The alliance will collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialisation.
Lonza and Genetix Biotherapeutics, a commercial-stage biotechnology company dedicated to delivering genetic therapies for patients with severe rare diseases, has announced the extension of their long-term commercial manufacturing agreement.
Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies.
SynGenSys, a biotech company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing, has announced the launch of its Liver.SET library of liver-specific synthetic promoters.
European Pharmaceutical Manufacturer spoke to pharma experts at Advanced Therapies Philadelphia about their 2026 predictions for both the industry and their companies.
Trenchant BioSystems, the CGT manufacturing platform developer for gene-modified cells, today announces multiple internal and independent external data readouts for the prototype of its AutoCell CGT manufacturing platform.
Title21 Health Solutions, a provider of enterprise quality management systems and cell and gene therapy orchestration platforms, has announced the acquisition of MyCellHub and its advanced manufacturing execution system (MES) platform.
